Page last updated: 2024-10-21

5-dimethylamiloride and Leukemia

5-dimethylamiloride has been researched along with Leukemia in 1 studies

5-dimethylamiloride: has anti-HIV-1 activity

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Mirossay, L1
Mirossay, A1
Kocisová, E1
Radváková, I1
Miskovský, P1
Mojzis, J1

Other Studies

1 other study available for 5-dimethylamiloride and Leukemia

ArticleYear
Hypericin-induced phototoxicity of human leukemic cell line HL-60 is potentiated by omeprazole, an inhibitor of H+K+-ATPase and 5'-(N,N-dimethyl)-amiloride, an inhibitor of Na+/H+ exchanger.
    Physiological research, 1999, Volume: 48, Issue:2

    Topics: Amiloride; Anthracenes; Antineoplastic Agents; Drug Synergism; Enzyme Inhibitors; HL-60 Cells; Human

1999